normative
All-cause mortality is the only endpoint that matters
Screening trials should be judged on all-cause mortality, not cancer-specific mortality, because the slippery-linkage bias means treatment-induced deaths (e.g., chemotherapy-caused leukemia, or post-diagnosis suicide) may be wrongly classified as unrelated; all-cause mortality is also the only thing patients ultimately care about.
normativepending
Speaker
Vinay PrasadEvidence Quote
“The other reason I like looking at all-cause death is that ultimately it's what patients care about.”
Created: 6/13/2026, 12:15:40 AM
Your notes
Loading notes...